- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.92 | - |
NAV | ₹40.39 | - |
Fund Started | 12 Nov 2018 | - |
Fund Size | ₹3138.46 Cr | - |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.92
-
NAV
₹40.39
-
Fund Started
12 Nov 2018
-
Fund Size
₹3138.46 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
Returns
1 Year | 46.41% | - |
3 Year | 21.24% | - |
5 Year | 30.71% | - |
1 Year
46.41%
-
3 Year
21.24%
-
5 Year
30.71%
-
Holding Analysis
Equity | 96.59% | - |
Cash | 3.41% | - |
Equity
96.59%
-
Cash
3.41%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.05% |
Suven Pharmaceuticals Ltd. | 10.82% |
Ipca Laboratories Ltd. | 8.12% |
Cipla Ltd. | 6.85% |
Illumina Inc. (USA) | 5.38% |
Globus Medical Inc | 5.30% |
Alembic Pharmaceuticals Ltd. | 5.12% |
Gland Pharma Ltd. | 4.33% |
Apollo Hospitals Enterprise Ltd. | 4.17% |
Lupin Ltd. | 3.84% |
-
Fund Manager
Name | Jay Kothari | - |
Start Date | 16 Mar 2018 | - |
Name
Jay Kothari
-
Start Date
16 Mar 2018
-
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | - |
Launch Date | 12 Nov 2018 | - |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
